Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

There's hope for U.S. cattle ranchers in the battle to stop the spread of screwworm at a time of decimated herds with the FDA ...

One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...

Patients with polycythemia vera (PV), a rare cancer characterized by overabundant red blood cells, have endured years of middling progress in their therapeutic options. | Patients with polycythemia ...

For example, Verizon carries a material amount of debt. That's not shocking, given the capital-intensive nature of running ...

Finally, Merck is an excellent dividend stock. It offers a juicy forward yield of 3.2% and has increased its payouts by 93.8% ...

Halozyme is seeing some progress in its global effort to defend intellectual property against alleged infringement by Merck & ...

Grupo Financiero Valores S.A. FRANKFURT, Nov 20 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration ...

(Reuters) -Merck and Eisai's experimental combination treatment helped extend the time certain patients with advanced kidney cell cancer lived without their disease progressing, according to interim ...